Show Summary Details
Page of

α‎2-Adrenergic Agonists: Clonidine and Guanfacine 

α‎2-Adrenergic Agonists: Clonidine and Guanfacine
Chapter:
α‎2-Adrenergic Agonists: Clonidine and Guanfacine
Author(s):

Jeffrey H. Newcorn

, Suzanne Clerkin

, Kurt P. Schulz

, and Jeffrey M. Halperin

DOI:
10.1093/med/9780195398212.003.0019
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 May 2020

Chapter 19 reviews the characteristics and regulatory properties of ??2 receptors, neuropharmacology of the ??2 - adrenergic agonists, and the hypothesized mechanisms by which these medications alter central nervous system (CNS) activity, as well as a variety of issues related to the clinical use of ??2 agonists, including safety and adverse effects, dosing, and medication interactions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.